Loading…

Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases

Objective  Angiotensin II type 1 receptor antagonists (ARA). Interacted with the renin–angiotensin system, and the present study was undertaken to examine their fetal and neonatal toxicity when taken by the mother during pregnancy. Design  Prospective follow up of pregnant women exposed to an ARA du...

Full description

Saved in:
Bibliographic Details
Published in:BJOG : an international journal of obstetrics and gynaecology 2005-06, Vol.112 (6), p.710-712
Main Authors: Serreau, Raphael, Luton, Dominique, Macher, Marie‐Alice, Delezoide, Anne‐Lise, Garel, Catherine, Jacqz‐Aigrain, Evelyne
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4255-4198d856be47956a42afa039ae6e0ac6da5ecec2d01d270f3a03cc4060bee85b3
cites cdi_FETCH-LOGICAL-c4255-4198d856be47956a42afa039ae6e0ac6da5ecec2d01d270f3a03cc4060bee85b3
container_end_page 712
container_issue 6
container_start_page 710
container_title BJOG : an international journal of obstetrics and gynaecology
container_volume 112
creator Serreau, Raphael
Luton, Dominique
Macher, Marie‐Alice
Delezoide, Anne‐Lise
Garel, Catherine
Jacqz‐Aigrain, Evelyne
description Objective  Angiotensin II type 1 receptor antagonists (ARA). Interacted with the renin–angiotensin system, and the present study was undertaken to examine their fetal and neonatal toxicity when taken by the mother during pregnancy. Design  Prospective follow up of pregnant women exposed to an ARA during early pregnancy. Setting  The present study was conducted in the departments of Paedriatric Pharmacology of the University hospital Robert Debré in Paris, France. Population  Ten women exposed to an ARA during early pregnancy. Methods  Prospective follow up. Main outcome measure  Fetal ultrasonography and outcome of pregnancy. Results  Prenatal ultrasonography showed abnormal features in five cases (oligoamnios related to fetal tabular dysgenesis, fetal dysmorphia and renal abnormalities). Outcome of pregnancy was as follows: three induced abortions, two stillbirths (twin pregnancy), one neonate presenting with dysmorphia and renal disease and five neonates with an uneventful development. Conclusion  Women of reproductive age should be advised of the possible hazards of ARA and treatment should be stopped as soon as pregnany has been documented.
doi_str_mv 10.1111/j.1471-0528.2004.00525.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_225582094</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>873114251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4255-4198d856be47956a42afa039ae6e0ac6da5ecec2d01d270f3a03cc4060bee85b3</originalsourceid><addsrcrecordid>eNqNkEuP0zAURi0EYh7wF5CFxDLh2rFThwUSMwxQNNJsYG25zk0nVWoH24Hm3-O0FbPFG1_pO_ehQwhlULL83u9KJlasAMlVyQFECbmU5eEZufwXPD_WUEDF1QW5inEHwGoO1UtywWTDheTikkyf8TcOftyjS2agyR9626eZ-o6mR6TGbXuf0MXe0fWapnlEymhAi2PyIcfJbL3rY4q0nULvtvRx2htHx4BbZ5ydP1CT8dGHtIxkQK2JGF-RF50ZIr4-_9fk55e7H7ffivuHr-vbT_eFFVzKQrBGtUrWGxSrRtZGcNMZqBqDNYKxdWtkvsTyFljLV9BVObRWQA0bRCU31TV5e5o7Bv9rwpj0zk_B5ZWa5wWKQyMypE6QDT7GgJ0eQ783YdYM9KJb7_RiVS9W9aJbH3XrQ259c54_bfbYPjWe_Wbg3Rkw0ZqhC9lJH5-4WjFZq1XmPp64P_2A838foG--PxzL6i-l0JwD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>225582094</pqid></control><display><type>article</type><title>Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Serreau, Raphael ; Luton, Dominique ; Macher, Marie‐Alice ; Delezoide, Anne‐Lise ; Garel, Catherine ; Jacqz‐Aigrain, Evelyne</creator><creatorcontrib>Serreau, Raphael ; Luton, Dominique ; Macher, Marie‐Alice ; Delezoide, Anne‐Lise ; Garel, Catherine ; Jacqz‐Aigrain, Evelyne</creatorcontrib><description>Objective  Angiotensin II type 1 receptor antagonists (ARA). Interacted with the renin–angiotensin system, and the present study was undertaken to examine their fetal and neonatal toxicity when taken by the mother during pregnancy. Design  Prospective follow up of pregnant women exposed to an ARA during early pregnancy. Setting  The present study was conducted in the departments of Paedriatric Pharmacology of the University hospital Robert Debré in Paris, France. Population  Ten women exposed to an ARA during early pregnancy. Methods  Prospective follow up. Main outcome measure  Fetal ultrasonography and outcome of pregnancy. Results  Prenatal ultrasonography showed abnormal features in five cases (oligoamnios related to fetal tabular dysgenesis, fetal dysmorphia and renal abnormalities). Outcome of pregnancy was as follows: three induced abortions, two stillbirths (twin pregnancy), one neonate presenting with dysmorphia and renal disease and five neonates with an uneventful development. Conclusion  Women of reproductive age should be advised of the possible hazards of ARA and treatment should be stopped as soon as pregnany has been documented.</description><identifier>ISSN: 1470-0328</identifier><identifier>EISSN: 1471-0528</identifier><identifier>DOI: 10.1111/j.1471-0528.2004.00525.x</identifier><identifier>PMID: 15924524</identifier><identifier>CODEN: BIOGFQ</identifier><language>eng</language><publisher>Oxford, UK and Malden, USA: Blackwell Science Ltd</publisher><subject>Abnormalities, Drug-Induced - diagnostic imaging ; Abnormalities, Drug-Induced - etiology ; Adult ; Angiotensin II Type 1 Receptor Blockers ; Antihypertensive Agents ; Biological and medical sciences ; Contraindications ; Female ; Fetus - abnormalities ; Follow-Up Studies ; Gynecology. Andrology. Obstetrics ; Humans ; Hypertension, Pregnancy-Induced - drug therapy ; Medical sciences ; Obstetrics ; Pregnancy ; Prospective Studies ; Proteins ; Renin-Angiotensin System - drug effects ; Teratogens - toxicity ; Toxicity ; Ultrasonography, Prenatal</subject><ispartof>BJOG : an international journal of obstetrics and gynaecology, 2005-06, Vol.112 (6), p.710-712</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright Elsevier Science Ltd. Jun 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4255-4198d856be47956a42afa039ae6e0ac6da5ecec2d01d270f3a03cc4060bee85b3</citedby><cites>FETCH-LOGICAL-c4255-4198d856be47956a42afa039ae6e0ac6da5ecec2d01d270f3a03cc4060bee85b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16815687$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15924524$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Serreau, Raphael</creatorcontrib><creatorcontrib>Luton, Dominique</creatorcontrib><creatorcontrib>Macher, Marie‐Alice</creatorcontrib><creatorcontrib>Delezoide, Anne‐Lise</creatorcontrib><creatorcontrib>Garel, Catherine</creatorcontrib><creatorcontrib>Jacqz‐Aigrain, Evelyne</creatorcontrib><title>Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases</title><title>BJOG : an international journal of obstetrics and gynaecology</title><addtitle>BJOG</addtitle><description>Objective  Angiotensin II type 1 receptor antagonists (ARA). Interacted with the renin–angiotensin system, and the present study was undertaken to examine their fetal and neonatal toxicity when taken by the mother during pregnancy. Design  Prospective follow up of pregnant women exposed to an ARA during early pregnancy. Setting  The present study was conducted in the departments of Paedriatric Pharmacology of the University hospital Robert Debré in Paris, France. Population  Ten women exposed to an ARA during early pregnancy. Methods  Prospective follow up. Main outcome measure  Fetal ultrasonography and outcome of pregnancy. Results  Prenatal ultrasonography showed abnormal features in five cases (oligoamnios related to fetal tabular dysgenesis, fetal dysmorphia and renal abnormalities). Outcome of pregnancy was as follows: three induced abortions, two stillbirths (twin pregnancy), one neonate presenting with dysmorphia and renal disease and five neonates with an uneventful development. Conclusion  Women of reproductive age should be advised of the possible hazards of ARA and treatment should be stopped as soon as pregnany has been documented.</description><subject>Abnormalities, Drug-Induced - diagnostic imaging</subject><subject>Abnormalities, Drug-Induced - etiology</subject><subject>Adult</subject><subject>Angiotensin II Type 1 Receptor Blockers</subject><subject>Antihypertensive Agents</subject><subject>Biological and medical sciences</subject><subject>Contraindications</subject><subject>Female</subject><subject>Fetus - abnormalities</subject><subject>Follow-Up Studies</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Hypertension, Pregnancy-Induced - drug therapy</subject><subject>Medical sciences</subject><subject>Obstetrics</subject><subject>Pregnancy</subject><subject>Prospective Studies</subject><subject>Proteins</subject><subject>Renin-Angiotensin System - drug effects</subject><subject>Teratogens - toxicity</subject><subject>Toxicity</subject><subject>Ultrasonography, Prenatal</subject><issn>1470-0328</issn><issn>1471-0528</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqNkEuP0zAURi0EYh7wF5CFxDLh2rFThwUSMwxQNNJsYG25zk0nVWoH24Hm3-O0FbPFG1_pO_ehQwhlULL83u9KJlasAMlVyQFECbmU5eEZufwXPD_WUEDF1QW5inEHwGoO1UtywWTDheTikkyf8TcOftyjS2agyR9626eZ-o6mR6TGbXuf0MXe0fWapnlEymhAi2PyIcfJbL3rY4q0nULvtvRx2htHx4BbZ5ydP1CT8dGHtIxkQK2JGF-RF50ZIr4-_9fk55e7H7ffivuHr-vbT_eFFVzKQrBGtUrWGxSrRtZGcNMZqBqDNYKxdWtkvsTyFljLV9BVObRWQA0bRCU31TV5e5o7Bv9rwpj0zk_B5ZWa5wWKQyMypE6QDT7GgJ0eQ783YdYM9KJb7_RiVS9W9aJbH3XrQ259c54_bfbYPjWe_Wbg3Rkw0ZqhC9lJH5-4WjFZq1XmPp64P_2A838foG--PxzL6i-l0JwD</recordid><startdate>200506</startdate><enddate>200506</enddate><creator>Serreau, Raphael</creator><creator>Luton, Dominique</creator><creator>Macher, Marie‐Alice</creator><creator>Delezoide, Anne‐Lise</creator><creator>Garel, Catherine</creator><creator>Jacqz‐Aigrain, Evelyne</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope></search><sort><creationdate>200506</creationdate><title>Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases</title><author>Serreau, Raphael ; Luton, Dominique ; Macher, Marie‐Alice ; Delezoide, Anne‐Lise ; Garel, Catherine ; Jacqz‐Aigrain, Evelyne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4255-4198d856be47956a42afa039ae6e0ac6da5ecec2d01d270f3a03cc4060bee85b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Abnormalities, Drug-Induced - diagnostic imaging</topic><topic>Abnormalities, Drug-Induced - etiology</topic><topic>Adult</topic><topic>Angiotensin II Type 1 Receptor Blockers</topic><topic>Antihypertensive Agents</topic><topic>Biological and medical sciences</topic><topic>Contraindications</topic><topic>Female</topic><topic>Fetus - abnormalities</topic><topic>Follow-Up Studies</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Hypertension, Pregnancy-Induced - drug therapy</topic><topic>Medical sciences</topic><topic>Obstetrics</topic><topic>Pregnancy</topic><topic>Prospective Studies</topic><topic>Proteins</topic><topic>Renin-Angiotensin System - drug effects</topic><topic>Teratogens - toxicity</topic><topic>Toxicity</topic><topic>Ultrasonography, Prenatal</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Serreau, Raphael</creatorcontrib><creatorcontrib>Luton, Dominique</creatorcontrib><creatorcontrib>Macher, Marie‐Alice</creatorcontrib><creatorcontrib>Delezoide, Anne‐Lise</creatorcontrib><creatorcontrib>Garel, Catherine</creatorcontrib><creatorcontrib>Jacqz‐Aigrain, Evelyne</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Serreau, Raphael</au><au>Luton, Dominique</au><au>Macher, Marie‐Alice</au><au>Delezoide, Anne‐Lise</au><au>Garel, Catherine</au><au>Jacqz‐Aigrain, Evelyne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases</atitle><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle><addtitle>BJOG</addtitle><date>2005-06</date><risdate>2005</risdate><volume>112</volume><issue>6</issue><spage>710</spage><epage>712</epage><pages>710-712</pages><issn>1470-0328</issn><eissn>1471-0528</eissn><coden>BIOGFQ</coden><abstract>Objective  Angiotensin II type 1 receptor antagonists (ARA). Interacted with the renin–angiotensin system, and the present study was undertaken to examine their fetal and neonatal toxicity when taken by the mother during pregnancy. Design  Prospective follow up of pregnant women exposed to an ARA during early pregnancy. Setting  The present study was conducted in the departments of Paedriatric Pharmacology of the University hospital Robert Debré in Paris, France. Population  Ten women exposed to an ARA during early pregnancy. Methods  Prospective follow up. Main outcome measure  Fetal ultrasonography and outcome of pregnancy. Results  Prenatal ultrasonography showed abnormal features in five cases (oligoamnios related to fetal tabular dysgenesis, fetal dysmorphia and renal abnormalities). Outcome of pregnancy was as follows: three induced abortions, two stillbirths (twin pregnancy), one neonate presenting with dysmorphia and renal disease and five neonates with an uneventful development. Conclusion  Women of reproductive age should be advised of the possible hazards of ARA and treatment should be stopped as soon as pregnany has been documented.</abstract><cop>Oxford, UK and Malden, USA</cop><pub>Blackwell Science Ltd</pub><pmid>15924524</pmid><doi>10.1111/j.1471-0528.2004.00525.x</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1470-0328
ispartof BJOG : an international journal of obstetrics and gynaecology, 2005-06, Vol.112 (6), p.710-712
issn 1470-0328
1471-0528
language eng
recordid cdi_proquest_journals_225582094
source Wiley-Blackwell Read & Publish Collection
subjects Abnormalities, Drug-Induced - diagnostic imaging
Abnormalities, Drug-Induced - etiology
Adult
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Biological and medical sciences
Contraindications
Female
Fetus - abnormalities
Follow-Up Studies
Gynecology. Andrology. Obstetrics
Humans
Hypertension, Pregnancy-Induced - drug therapy
Medical sciences
Obstetrics
Pregnancy
Prospective Studies
Proteins
Renin-Angiotensin System - drug effects
Teratogens - toxicity
Toxicity
Ultrasonography, Prenatal
title Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T11%3A11%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Developmental%20toxicity%20of%20the%20angiotensin%20II%20type%201%20receptor%20antagonists%20during%20human%20pregnancy:%20a%20report%20of%2010%20cases&rft.jtitle=BJOG%20:%20an%20international%20journal%20of%20obstetrics%20and%20gynaecology&rft.au=Serreau,%20Raphael&rft.date=2005-06&rft.volume=112&rft.issue=6&rft.spage=710&rft.epage=712&rft.pages=710-712&rft.issn=1470-0328&rft.eissn=1471-0528&rft.coden=BIOGFQ&rft_id=info:doi/10.1111/j.1471-0528.2004.00525.x&rft_dat=%3Cproquest_cross%3E873114251%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4255-4198d856be47956a42afa039ae6e0ac6da5ecec2d01d270f3a03cc4060bee85b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=225582094&rft_id=info:pmid/15924524&rfr_iscdi=true